Cited by 86Protein Kinase Regulation and GTPase SignalingBladder and Urothelial Cancer TreatmentsTGF-β signaling in diseases

Review Article: The Role of Ras Superfamily Proteins in Bladder Cancer Progression

OXFORD, GARY, THEODORESCU, DAN·2003·Journal of Urology

Abstract

Purpose The prognosis of patients with bladder cancer is strongly dependent on whether the lesion is superficial or invasive at initial presentation. In addition, a significant fraction of patients presenting with superficial disease have invasive tumor during followup. Understanding how superficial bladder cancer progresses to invasive forms of the disease is of paramount importance for early diagnosis and successful treatment. Molecular mechanisms underlying bladder cancer progression are being elucidated. We reviewed the roles that members of the Ras superfamily of monomeric G proteins, an important class of cellular regulator, have in bladder cancer and its progression. Materials and methods We performed MEDLINE searches focusing on members of the Ras superfamily of monomeric G proteins and their involvement in transitional cell carcinoma, which is the most common form of bladder cancer. General involvement in cancer of key superfamily members, focusing on mechanisms and downstream pathways, was also reviewed through MEDLINE and manual bibliographic searches. Results With more than 100 members in humans the Ras superfamily is a diverse group of monomeric G proteins. These proteins regulate many cellular processes, such as cell cycle progression, actin cytoskeletal dynamics and membrane traffic. Members of the Ras and Rho family are also known to be involved in human cancer through mutation, over expression and dysregulation. In this review we focus on bladder cancer. In p…

Integrity signals

Registry

Crossref · 10.1097/01.ju.0000088670.02905.78

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Overactivation of RHO subfamily GTPases such as RAC1 and CDC42 promotes hyperactivation of critical signaling cascades leading to cancer.

    “However, overactivation of the RHO subfamily such as RAS-related C3 botulinum toxin substrate 1 (RAC1) and cell division cycle 42 homolog (CDC42) are also known to promote the hyperactivation of critical signaling cascades leading to cancer (10, 13, 17).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
OXFORD, G., & THEODORESCU, D.
Affiliations
University of Virginia (US)
Venue
Journal of Urology
Published
2003-11
Volume
170
Issue
5
Pages
1987-1993
ISSN
  • 0022-5347 (ISSN-L)
  • 1527-3792
OpenAlex
W2040543332
Cited by
86
References
2
Citations by year
2025: 2 · 2024: 2 · 2022: 1 · 2021: 4 · 2020: 2 · 2019: 2 · 2018: 1 · 2017: 4 · 2016: 4 · 2015: 3 · 2014: 1 · 2013: 3 · 2012: 10
FWCI
1.37
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Urology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Health Sciences › Medicine › Surgery › Bladder and Urothelial Cancer Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Keywords
Ras superfamily, bladder cancer progression, H-Ras, RhoGDI2, Rho family, urothelial carcinoma, epidermal growth factor receptor, p53, PTEN, signaling pathways, therapeutic target
MeSH terms
Urinary Bladder, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Humans, Neoplasm Invasiveness, Signal Transduction, Disease Progression, ras Proteins, Monomeric GTP-Binding Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review